Ethical implications of research on craving

Carter, Adrian and Hall, Wayne (2013) Ethical implications of research on craving. Addictive Behaviors, 38 2: 1593-1599. doi:10.1016/j.addbeh.2012.07.002

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
UQ291526_OA.pdf Full text (open access) application/pdf 114.92KB 4

Author Carter, Adrian
Hall, Wayne
Title Ethical implications of research on craving
Journal name Addictive Behaviors   Check publisher's open access policy
ISSN 0306-4603
Publication date 2013-02
Year available 2012
Sub-type Article (original research)
DOI 10.1016/j.addbeh.2012.07.002
Open Access Status File (Author Post-print)
Volume 38
Issue 2
Start page 1593
End page 1599
Total pages 7
Place of publication Kidlington, Oxford, United Kingdom
Publisher Pergamon
Collection year 2013
Language eng
Abstract Cravings, intense desires to experience the effects of a drug, are widely regarded as significant impediments to overcoming addiction, although their role in relapse may be overstated. Scientists and clinicians wish to better understand the neurobiological and cognitive basis of craving so that they may develop psychotherapeutic, pharmacological and other medical methods to reduce craving and thereby drug use. The conduct of such research raises significant ethical issues. When recruiting individuals and conducting this research, scientists need to ensure that substance dependent participants have the capacity to provide free and uncoerced consent. This is especially the case in studies in which dependent participants are given their drug of addiction or provided with other inducements to participate (e.g. financial incentives) that may undermine their ability to fully consider the risks of participation.Treatments for addiction that seek to reduce cravings may also carry risks. This includes psychotherapeutic approaches, as well as pharmacological and medical treatments. Clinicians need to consider the risks and benefits of treatment and carefully communicate these to patients. The desire to reduce urges to use drugs should not be employed to justify potentially harmful and ineffective treatments. The safety and effectiveness of emerging treatments should be assessed by well conducted randomized controlled clinical trials.
Keyword Craving
Informed consent
Anti-craving drugs
Deep brain stimulation
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: UQ Centre for Clinical Research Publications
Queensland Brain Institute Publications
Official 2013 Collection
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Scopus Citation Count Cited 2 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 17 Feb 2013, 00:08:30 EST by System User on behalf of UQ Centre for Clinical Research